Liminatus Pharma, Inc. — Investor Relations & Filings
Filings indexed
83
across all filing types
Latest filing
2025-08-15
Regulatory Filings
Country
US
United States of America
Listing
US
LIMN
Liminatus Pharma, Inc. is a pre-clinical-stage biopharmaceutical company focused on developing novel, immune-modulating cancer therapies. The company specializes in immuno-oncology and is pioneering the development of a second-generation CD47-blockade antibody. This therapeutic approach is designed to utilize the patient's immune system to target and destroy cancer cells. Its lead clinical candidate, IBA101, is a humanized anti-CD47 antibody being advanced toward clinical trials for the treatment of various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NT 10-Q | 2025-08-15 | English | |
| FORM 8-K | 2025-08-14 | English | |
| 424B3 | 2025-08-13 | English | |
| Regulatory Filings 2025 | 2025-08-13 | English | |
| Regulatory Filings 2025 | 2025-08-11 | English | |
| S-1/A | 2025-07-26 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13651424 | NT 10-Q | 2025-08-15 | English | ||
| 13651427 | FORM 8-K | 2025-08-14 | English | ||
| 13651429 | 424B3 | 2025-08-13 | English | ||
| 13651430 | Regulatory Filings 2025 | 2025-08-13 | English | ||
| 13651431 | Regulatory Filings 2025 | 2025-08-11 | English | ||
| 13651453 | S-1/A | 2025-07-26 | English | ||
| 13651433 | Regulatory Filings 2025 | 2025-07-26 | English | ||
| 13651439 | OWNERSHIP DOCUMENT | 2025-07-23 | English | ||
| 13651440 | OWNERSHIP DOCUMENT | 2025-07-21 | English | ||
| 13651441 | FORM 8-K | 2025-07-17 | English | ||
| 13651442 | FORM 8-K | 2025-07-11 | English | ||
| 13651434 | Regulatory Filings 2025 | 2025-07-03 | English | ||
| 13651435 | FORM 8-K | 2025-07-03 | English | ||
| 13651436 | Major Shareholding Notification 2025 | 2025-06-28 | English | ||
| 13651443 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 2025-06-28 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Liminatus Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34636/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34636 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34636 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34636 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34636}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Liminatus Pharma, Inc. (id: 34636)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.